On November 25, 2022, Caoli, a first-class researcher of the science and Education Department of Sichuan Provincial Health Commission, sunxuemei, a second-class researcher, and teachers Su Jie, sunchenghong, and luoyanling visited Chengdu Shilian Health Biotechnology Co., Ltd. for work guidance and exchange.
Professor tianweidong, founder and chief scientist of Chengdu Shilian Health Biotechnology Co., Ltd., tangyingfeng, general manager and other company managers attended the reception and exchange.
Professor tianweidong, the founder and chief scientist of the company, extended a warm welcome to the leading experts of Sichuan Provincial Health Commission. Professor tianweidong said that in the development process, the company always adhered to the overall development idea of "building a platform, cultivating talents, incubating projects and cultivating industries", took stem cell clinical therapy research and cell drug R & D and transformation application as development goals, and built a quality management system in strict accordance with GMP standards. Relying on the national and local joint Engineering Laboratory of oral regenerative medicine, the engineering research center of the Ministry of oral translational medicine, West China Hospital of Sichuan University, West China stomatological hospital, West China Second Hospital and other R & D and medical institutions, the company has built a platform for the transformation of scientific research achievements into industry, helped the industrialization of scientific research achievements in the field of cell technology in Sichuan Province, and made efforts to launch clinical drugs to fill the domestic gap of stem cell drug therapy.
Tangyingfeng, general manager, introduced the overall development of Chengdu Shilian Health Biotechnology Co., Ltd. and Sichuan Cell Bank Co., Ltd. and the implementation of the world's first dental follicle stem cell clinical treatment filed with the National Health Commission. Zhang Jingyi, the manager of the quality department, made a detailed report on the construction of the company's quality management system.
Caoli, a first-class researcher of the Sichuan Provincial Health Commission, gave positive affirmation to the company's overall development, production quality management and other work. Leading experts of the Sichuan Provincial Health Commission and the company's participants carried out in-depth discussions on the industry's development status, national policies and regulations, cell quality standards, cell production management, quality system construction, clinical drug research and development and other aspects.
At the end of the exchange, Professor tianweidong and general manager tangyingfeng accompanied the leading experts of the health commission to visit the company and took a group photo.
